The NAD+ 1000mg & Retatrutide: The UK Innovation in Cellular Function
Emerging research from the UK are generating considerable excitement surrounding the potential combination of high-dose NAD+ supplementation (1000mg) and the novel GLP-1 receptor agonist, Retatrutide. This intriguing approach aims to improve multiple facets of metabolic disorder, potentially offe